Investing.com - Portage Biotech Inc reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Portage Biotech Inc announced earnings per share of $-0.06 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.29 on revenue of $0.00.
Portage Biotech Inc shares are down 44% from the beginning of the year and are trading at $5.96 , down-from-52-week-high.
Portage Biotech Inc follows other major Healthcare sector earnings this month
Portage Biotech Inc's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on November 1 with third quarter EPS of $1.78 on revenue of $22.6B, compared to forecast for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar